470 related articles for article (PubMed ID: 31690696)
1. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
[TBL] [Abstract][Full Text] [Related]
2. Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10.
Liu T; Woo JA; Bukhari MZ; Wang X; Yan Y; Buosi SC; Ermekbaeva A; Sista A; Kotsiviras P; LePochat P; Chacko A; Zhao X; Kang DE
Acta Neuropathol Commun; 2022 Jul; 10(1):95. PubMed ID: 35787294
[TBL] [Abstract][Full Text] [Related]
3. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases.
Genin EC; Bannwarth S; Lespinasse F; Ortega-Vila B; Fragaki K; Itoh K; Villa E; Lacas-Gervais S; Jokela M; Auranen M; Ylikallio E; Mauri-Crouzet A; Tyynismaa H; Vihola A; Augé G; Cochaud C; Sesaki H; Ricci JE; Udd B; Vives-Bauza C; Paquis-Flucklinger V
Neurobiol Dis; 2018 Nov; 119():159-171. PubMed ID: 30092269
[TBL] [Abstract][Full Text] [Related]
4. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.
Chaussenot A; Le Ber I; Ait-El-Mkadem S; Camuzat A; de Septenville A; Bannwarth S; Genin EC; Serre V; Augé G; ; Brice A; Pouget J; Paquis-Flucklinger V
Neurobiol Aging; 2014 Dec; 35(12):2884.e1-2884.e4. PubMed ID: 25155093
[TBL] [Abstract][Full Text] [Related]
5. Disruption of Mitophagy Flux through the PARL-PINK1 Pathway by CHCHD10 Mutations or CHCHD10 Depletion.
Liu T; Wetzel L; Zhu Z; Kumaraguru P; Gorthi V; Yan Y; Bukhari MZ; Ermekbaeva A; Jeon H; Kee TR; Woo JA; Kang DE
Cells; 2023 Dec; 12(24):. PubMed ID: 38132101
[TBL] [Abstract][Full Text] [Related]
6. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement.
Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore DG; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
Brain; 2014 Aug; 137(Pt 8):2329-45. PubMed ID: 24934289
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 and PINK1 mediate CHCHD10
Baek M; Choe YJ; Bannwarth S; Kim J; Maitra S; Dorn GW; Taylor JP; Paquis-Flucklinger V; Kim NC
Nat Commun; 2021 Mar; 12(1):1924. PubMed ID: 33772006
[TBL] [Abstract][Full Text] [Related]
8. CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.
Liu T; Woo JA; Bukhari MZ; LePochat P; Chacko A; Selenica MB; Yan Y; Kotsiviras P; Buosi SC; Zhao X; Kang DE
FASEB J; 2020 Jun; 34(6):8493-8509. PubMed ID: 32369233
[TBL] [Abstract][Full Text] [Related]
9. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity.
Woo JA; Liu T; Trotter C; Fang CC; De Narvaez E; LePochat P; Maslar D; Bukhari A; Zhao X; Deonarine A; Westerheide SD; Kang DE
Nat Commun; 2017 Jun; 8():15558. PubMed ID: 28585542
[TBL] [Abstract][Full Text] [Related]
10. Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.
Higgins NR; Greenslade JE; Wu JJ; Miranda E; Galliciotti G; Monteiro MJ
Brain Pathol; 2021 Sep; 31(5):e12948. PubMed ID: 33780087
[TBL] [Abstract][Full Text] [Related]
11. Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients.
Perrone F; Nguyen HP; Van Mossevelde S; Moisse M; Sieben A; Santens P; De Bleecker J; Vandenbulcke M; Engelborghs S; Baets J; Cras P; Vandenberghe R; De Jonghe P; De Deyn PP; Martin JJ; Van Damme P; Van Broeckhoven C; van der Zee J;
Neurobiol Aging; 2017 Mar; 51():177.e9-177.e16. PubMed ID: 28069311
[TBL] [Abstract][Full Text] [Related]
12. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
13. Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia.
Nementzik LR; Thumbadoo KM; Murray HC; Gordon D; Yang S; Blair IP; Turner C; Faull RLM; Curtis MA; McLean C; Nicholson GA; Swanson MEV; Scotter EL
Brain Pathol; 2024 May; 34(3):e13230. PubMed ID: 38115557
[TBL] [Abstract][Full Text] [Related]
14. Family-based exome sequencing identifies RBM45 as a possible candidate gene for frontotemporal dementia and amyotrophic lateral sclerosis.
van der Zee J; Dillen L; Baradaran-Heravi Y; Gossye H; Koçoğlu C; Cuyt I; Dermaut B; Sieben A; Baets J; De Jonghe P; Vandenberghe R; De Deyn P; Cras P; Engelborghs S; Van Broeckhoven C;
Neurobiol Dis; 2021 Aug; 156():105421. PubMed ID: 34118419
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis.
Dewan R; Chia R; Ding J; Hickman RA; Stein TD; Abramzon Y; Ahmed S; Sabir MS; Portley MK; Tucci A; Ibáñez K; Shankaracharya FNU; Keagle P; Rossi G; Caroppo P; Tagliavini F; Waldo ML; Johansson PM; Nilsson CF; ; ; ; ; ; ; ; ; Rowe JB; Benussi L; Binetti G; Ghidoni R; Jabbari E; Viollet C; Glass JD; Singleton AB; Silani V; Ross OA; Ryten M; Torkamani A; Tanaka T; Ferrucci L; Resnick SM; Pickering-Brown S; Brady CB; Kowal N; Hardy JA; Van Deerlin V; Vonsattel JP; Harms MB; Morris HR; Ferrari R; Landers JE; Chiò A; Gibbs JR; Dalgard CL; Scholz SW; Traynor BJ
Neuron; 2021 Feb; 109(3):448-460.e4. PubMed ID: 33242422
[TBL] [Abstract][Full Text] [Related]
16. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
[TBL] [Abstract][Full Text] [Related]
17. A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.
Umoh ME; Dammer EB; Dai J; Duong DM; Lah JJ; Levey AI; Gearing M; Glass JD; Seyfried NT
EMBO Mol Med; 2018 Jan; 10(1):48-62. PubMed ID: 29191947
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
[TBL] [Abstract][Full Text] [Related]
19. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
[TBL] [Abstract][Full Text] [Related]
20. Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Kirola L; Mukherjee A; Mutsuddi M
Mol Neurobiol; 2022 Sep; 59(9):5673-5694. PubMed ID: 35768750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
